What is the competitive landscape for JANSSEN PHARMS, and when can generic versions of JANSSEN PHARMS drugs launch?
has fifty-six approved drugs.
There are thirty-seven US patents protecting JANSSEN PHARMS drugs and there have been four Paragraph IV challenges on JANSSEN PHARMS drugs in the past three years.
There are seven hundred and eighty-one patent family members
on JANSSEN PHARMS drugs in fifty-seven countries and seventy-three supplementary protection certificates
in fifteen countries.